minimal Common Oncology Data Elements (mCODE) Implementation Guide
3.0.0-ballot - 2023May United States of America flag

This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v3.0.0-ballot: STU 3 Ballot 1) based on FHIR R4. The current version which supercedes this version is 2.1.0. For a full list of available versions, see the Directory of published versions

Example MedicationRequest: cancer-related-medication-request-cisplatin

Generated Narrative: MedicationRequest

Resource MedicationRequest "cancer-related-medication-request-cisplatin"

Profile: Cancer-Related Medication Request Profile

Procedure Intent Extension: Curative - procedure intent (SNOMED CT[Intl]#373808002)

Treatment Termination Reason Extension: Treatment completed (situation) (SNOMED CT[Intl]#182992009)

status: active

intent: order

medication: CISplatin 50 MG per 50 ML Injectable Solution (RxNorm#309311)

subject: Patient/cancer-patient-john-anyperson " ANYPERSON"

authoredOn: 2019-04-01

requester: Practitioner/us-core-practitioner-kyle-anydoc " ANYDOC"

reasonCode: Non-small cell lung cancer (disorder) (SNOMED CT[Intl]#254637007)

note: Day 1 of NSCLC regimen: Cisplatin 75 mg/m2 day 1; docetaxel 75 mg/m2 day 1 every 21 days for 4 cycles.

dosageInstruction

text: calculate absolute dose on day of administration.

timing: Events: 2019-06-15, Count 1 times, Once

route: Intravenous use (SNOMED CT[Intl]#47625008)

doseAndRate